Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2020 Publisher: Santen Oy, Niittyhaankatu 20, 33720 Tampere, Finland
Oftaquix 5 mg/ml eye drops, solution.
| Pharmaceutical Form |
|---|
|
Eye drops, solution. Clear, light yellow to light greenish-yellow solution, practically free of visible particulate matter. Isotonic solution adjusted to physiological pH-value range. |
One ml of eye drops, solution, contains 5.12 mg of levofloxacin hemihydrate equivalent to 5 mg of levofloxacin.
Excipient with known effect: One ml of eye drops solution contains 0.05 mg benzalkonium chloride and one drop contains approximately 0.002 mg of benzalkonium chloride.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Levofloxacin |
Levofloxacin is a synthetic antibacterial agent of the fluoroquinolone class. As a fluoroquinolone antibacterial agent, levofloxacin acts on the DNA – DNA-gyrase complex and topoisomerase IV. |
| List of Excipients |
|---|
|
Benzalkonium chloride (0.05 mg in 1 ml eye drops, solution) |
5 ml of solution is supplied in a 5 ml white low-density polyethylene (LDPE) bottle with a LDPE dropper tip and a tan high-density polyethylene (HDPE) screw cap.
Pack size: 1 × 5 ml.
Santen Oy, Niittyhaankatu 20, 33720 Tampere, Finland
PL 16058/0006
Date of latest renewal: 29 July 2006
| Drug | Countries | |
|---|---|---|
| OFTAQUIX | Austria, Estonia, Finland, Lithuania, Malta, Poland, Romania, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
